Previous Page  34 / 220 Next Page
Information
Show Menu
Previous Page 34 / 220 Next Page
Page Background

臺灣農藥科學 第

1

32

Pesticide Sex Endpoint

BM

4)

AIC SR

5)

P BMD BMDL

BMD/

BMDL

RN

6)

Propoxur NA Bladder

hyperplasia

LL 61 0

1

202 74

2.73 (54, 55)

Dicofol

NA Liver ad-

enoma

LL 83 0

1

22

15

1.47 (17)

NA Hepatocel-

luar carci-

noma

LL 197 -0.55 0.03 10

5

2

Etofen-

prox

NA Adrenal

vacuolation

LL 358 0.52 0.87 29

16

1.81 (29)

NA Adrenal

vacuolation

LL 197 -0.08 0.05 83

30

2.77

Fenari-

mol

NA Hyperpal-

stic nodule

LL 64 -0.14 0.46 5

3

1.67 (30)

NA Hepatic

adenoma

LL 33 -0.04 0.95 11

6

1.83

Bifen-

thrin

NA Bladder

leiomyosar-

coma

P 274 1.95 0

18

15

1.2

(5)

Flusila-

zole

NA Hepatocel-

lular vacu-

olation

LL 72 -0.59 0.90 27

11

2.45 (35)

NA Hepatocel-

lular vacu-

olation

LL 86 -0.09 0.60 12

7

1.71

NA Hydrone-

phrosis

G 221 -1.83 0

0.49 0.41 1.2

NA Liver acido-

philic foci

LL 153 0.01 0.97 5

2

2.5

NA Liver dif-

fuse fat

LL 266 0.05 0.88 2.25 1.12 2.01

表一、分析

31

種農藥之基準劑量與其最適模式、相關參數及資料來源(續)

Table 1.

Parameters and source of BMD analysis for the 31 pesticide risk assessment models

(continued)